Activated protein C ameliorates renal ischemia-reperfusion injury by restricting Y-box binding protein-1 ubiquitination

Journal of the American Society of Nephrology

Volumn 26, Issue 11, 2015, Pages 2789-2799

  Dong, Wei ^a   Wang, Hongjie ^a,b   Shahzad, Khurrum ^a,c   Bock, Fabian ^a   Al Dabet, Moh'D Mohanad ^a   Ranjan, Satish ^a   Wolter, Juliane ^a   Kohli, Shrey ^a   Hoffmann, Juliane ^a   Dhople, Vishnu Mukund ^d   Zhu, Cheng ^a   Lindquist, Jonathan A ^a   Esmon, Charles T ^e   Gröne, Elisabeth ^f   Gröne, Herman Josef ^f   Madhusudhan, Thati ^a   Mertens, Peter R ^a   Schlüter, Dirk ^a   Isermann, Berend ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^d UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^e UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; CREATININE; DEUBIQUITINASE; ENDOTHELIAL PROTEIN C RECEPTOR; KIDNEY INJURY MOLECULE 1; PROTEINASE ACTIVATED RECEPTOR 1; Y BOX BINDING PROTEIN 1; ANTICOAGULANT AGENT; CYSTEINE PROTEINASE; OTUBAIN 1 PROTEIN, MOUSE; OXYGEN; PROTEIN C; TRANSCRIPTION FACTOR; YB-1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY ISCHEMIA; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RENAL PROTECTION; REOXYGENATION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UBIQUITINATION; UREA NITROGEN BLOOD LEVEL; ALLELE; ANIMAL; C57BL MOUSE; CHEMISTRY; CROSS BREEDING; DISEASE MODEL; EXON; GENETICS; HYPOXIA; KIDNEY; KIDNEY TUBULE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; THROMBOSIS; TRANSGENIC MOUSE;

ALLELES; ANIMALS; ANTICOAGULANTS; CROSSES, GENETIC; CYSTEINE ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; EXONS; HYPOXIA; KIDNEY; KIDNEY TUBULES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OXYGEN; PROTEIN C; REPERFUSION INJURY; SIGNAL TRANSDUCTION; THROMBOSIS; TRANSCRIPTION FACTORS; UBIQUITINATION;

EID: 84946014189     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014080846     Document Type: Article

References (61)

1. Luong A, Fragiadaki M, Smith J, Boyle J, Lutz J, Dean JL, Harten S, Ashcroft M, Walmsley SR, Haskard DO, Maxwell PH, Walczak H, Pusey C, Evans PC: Cezanne regulates inflammatory responses to hypoxia in endothelial cells by targeting TRAF6 for deubiquitination. Circ Res 112: 1583-1591, 2013
2. Eltzschig HK, Eckle T: Ischemia and reperfusion-from mechanism to translation. Nat Med 17: 1391-1401, 2011
3. Liu S, Soong Y, Seshan SV, Szeto HH: Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis. Am J Physiol Renal Physiol 306: F970-F980, 2014
4. Lu CY, Winterberg PD, Chen J, Hartono JR: Acute kidney injury: A conspiracy of toll-like receptor 4 on endothelia, leukocytes, and tubules. Pediatr Nephrol 27: 1847-1854, 2012
5. Sevastos J, Kennedy SE, Davis DR, SamM, Peake PW, Charlesworth JA, Mackman N, Erlich JH: Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury. Blood 109: 577-583, 2007
6. Isermann B, Vinnikov IA, Madhusudhan T, Herzog S, Kashif M, Blautzik J, CoratMA, ZeierM, Blessing E,Oh J, Gerlitz B, Berg DT, Grinnell BW, Chavakis T, Esmon CT, Weiler H, Bierhaus A, Nawroth PP: Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med 13: 1349-1358, 2007
7. Bock F, Shahzad K,Wang H, Stoyanov S,Wolter J, DongW, Pelicci PG, Kashif M, Ranjan S, Schmidt S, Ritzel R, Schwenger V, Reymann KG, EsmonCT,Madhusudhan T,Nawroth PP, Isermann B: Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc. Proc Natl Acad Sci U S A 110: 648-653, 2013
8. Gupta A, Gerlitz B, Richardson MA, Bull C, Berg DT, Syed S, Galbreath EJ, Swanson BA, Jones BE, Grinnell BW: Distinct functions of activated protein C differentially attenuate acute kidney injury. J AmSoc Nephrol 20: 267-277, 2009
9. Gupta A,WilliamsMD, Macias WL,Molitoris BA,GrinnellBW: Activated protein C and acute kidney injury: Selective targeting of PAR-1. Curr Drug Targets 10: 1212-1226, 2009
10. Weiler H, Isermann BH: Thrombomodulin. J Thromb Haemost 1: 1515 1524, 2003
11. Sharfuddin AA, Sandoval RM, Berg DT, McDougal GE, Campos SB, Phillips CL, Jones BE, Gupta A, Grinnell BW, Molitoris BA: Soluble thrombomodulin protects ischemic kidneys. J Am Soc Nephrol 20: 524-534, 2009
12. Ozaki T, Anas C, Maruyama S, Yamamoto T, Yasuda K,Morita Y, Ito Y, GotohM, Yuzawa Y,Matsuo S: Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure. Nephrol Dial Transplant 23: 110-119, 2008.
13. Conway EM, Van de Wouwer M, Pollefeyt S, Jurk K, Van Aken H, De Vriese A, Weitz JI, Weiler H, Hellings PW, Schaeffer P, Herbert JM, Collen D, Theilmeier G: The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways. J ExpMed 196: 565-577, 2002
14. Van deWouwerM, Collen D, Conway EM: Thrombomodulin-protein CEPCR system: Integrated to regulate coagulation and inflammation. Arterioscler Thromb Vasc Biol 24: 1374-1383, 2004
15. Park SW, Chen SW, Kim M, D'Agati VD, Lee HT: Human activated protein C attenuates both hepatic and renal injury caused by hepatic ischemia and reperfusion injury in mice. Kidney Int 76: 739-750, 2009
16. Raffetseder U, Wernert N, Ostendorf T, van Roeyen C, Rauen T, Behrens P, Floege J, Mertens PR: Mesangial cell expression of protooncogene Ets-1 during progression of mesangioproliferative glomerulonephritis. Kidney Int 66: 622-632, 2004
17. Raffetseder U, Liehn EA, Weber C, Mertens PR: Role of cold shock Ybox protein-1 in inflammation, atherosclerosis and organ transplant rejection. Eur J Cell Biol 91: 567-575, 2012
18. Raffetseder U, Rauen T, Boor P, Ostendorf T, Hanssen L, Floege J, En Nia A, Djudjaj S, Frye BC, Mertens PR: Extracellular YB-1 blockade in experimental nephritis upregulates Notch-3 receptor expression and signaling. Nephron Exp Nephrol 118: e100-e108, 2011
19. Hanssen L, Alidousty C, Djudjaj S, Frye BC, Rauen T, Boor P, Mertens PR, van Roeyen CR, Tacke F, Heymann F, Tittel AP, Koch A, Floege J, Ostendorf T, Raffetseder U: YB-1 is an early and central mediator of bacterial and sterile inflammation in vivo. J Immunol 191: 2604-2613, 2013
20. Eliseeva IA, Kim ER, Guryanov SG, Ovchinnikov LP, Lyabin DN: Y-boxbinding protein 1 (YB-1) and its functions. Biochemistry (Mosc) 76: 1402-1433, 2011
21. Lindquist JA, Brandt S, Bernhardt A, Zhu C,Mertens PR: The role of cold shock domain proteins in inflammatory diseases. J Mol Med (Berl) 92: 207-216, 2014
22. Stenina OI, Poptic EJ, DiCorleto PE: Thrombin activates a Y boxbinding protein (DNA-binding protein B) in endothelial cells. J Clin Invest 106: 579-587, 2000
23. SteninaOI, Shaneyfelt KM,DiCorleto PE: Thrombin induces the release of the Y-box protein dbpB from mRNA: A mechanism of transcriptional activation. Proc Natl Acad Sci U S A 98: 7277-7282, 2001
24. Weiler-Guettler H, Christie PD, Beeler DL, Healy AM, Hancock WW, Rayburn H, Edelberg JM, Rosenberg RD: A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J Clin Invest 101: 1983-1991, 1998
25. Madhusudhan T, Wang H, Straub BK, Gröne E, Zhou Q, Shahzad K, Müller-Krebs S, Schwenger V, Gerlitz B, Grinnell BW, Griffin JH, Reiser J, Gröne HJ, Esmon CT, Nawroth PP, Isermann B: Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes. Blood 119: 874-883, 2012
26. Sinha D, Wang Z, Price VR, Schwartz JH, LieberthalW: Chemical anoxia of tubular cells induces activation of c-Src and its translocation to the zonula adherens. Am J Physiol Renal Physiol 284: F488-F497, 2003
27. Takacs-Jarrett M, Sweeney WE, Avner ED, Cotton CU: Morphological and functional characterization of a conditionally immortalized collecting tubule cell line. Am J Physiol 275: F802-F811, 1998
28. Uchiumi T, Fotovati A, Sasaguri T, Shibahara K, Shimada T, Fukuda T, Nakamura T, Izumi H, Tsuzuki T, KuwanoM, Kohno K: YB-1 is important for an early stage embryonic development: Neural tube formation and cell proliferation. J Biol Chem 281: 40440-40449, 2006
29. Lu ZH, Books JT, Ley TJ: YB-1 is important for late-stage embryonic development, optimal cellular stress responses, and the prevention of premature senescence. Mol Cell Biol 25: 4625-4637, 2005
30. Klinge S, Voigts-Hoffmann F, LeibundgutM, Arpagaus S, Ban N:Crystal structure of the eukaryotic 60S ribosomal subunit in complex with initiation factor 6. Science 334: 941-948, 2011
31. Pickart CM, Fushman D: Polyubiquitin chains: Polymeric protein signals. Curr Opin Chem Biol 8: 610-616, 2004
32. Petrova DT, Brehmer F, Schultze FC, Asif AR, Gross O, Oellerich M, Brandhorst G: Differential kidney proteome profiling in amurinemodel of renal fibrosis under treatment with mycophenolate mofetil. Pathobiology 78: 162-170, 2011.
33. Mosnier LO, Sinha RK, Burnier L, Bouwens EA, Griffin JH: Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46. Blood 120: 5237-5246, 2012
34. Joyce DE, Grinnell BW: Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappaB. Crit Care Med 30[Suppl]: S288 S293, 2002
35. Brueckmann M, Marx A, Weiler HM, Liebe V, Lang S, Kaden JJ, Zieger W, Borggrefe M, Huhle G, Konstantin Haase K: Stabilization of monocyte chemoattractant protein-1-mRNA by activated protein C. Thromb Haemost 89: 149-160, 2003
36. Sorokin AV, Selyutina AA, Skabkin MA, Guryanov SG, Nazimov IV, Richard C, Th'ng J, Yau J, Sorensen PH,Ovchinnikov LP, Evdokimova V: Proteasome-mediated cleavage of the Y-box-binding protein 1 is linked to DNA-damage stress response. EMBO J 24: 3602-3612, 2005
37. Lutz M, Wempe F, Bahr I, Zopf D, von Melchner H: Proteasomal degradation of the multifunctional regulator YB-1 is mediated by an F-Box protein induced during programmed cell death. FEBS Lett 580: 3921 3930, 2006
38. ChibiM,MeyerM, Skepu A, G Rees DJ, Moolman-Smook JC, Pugh DJ: RBBP6 interacts with multifunctional protein YB-1 through its RING finger domain, leading to ubiquitination and proteosomal degradation of YB-1. J Mol Biol 384: 908-916, 2008
39. Lawson EA, Miller KK, Bredella MA, Phan C, Misra M, Meenaghan E, Rosenblum L, Donoho D, Gupta R, Klibanski A: Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. Bone 46: 458-463, 2010
40. Goncharov T, Niessen K, de Almagro MC, Izrael-Tomasevic A, Fedorova AV, Varfolomeev E, Arnott D, Deshayes K, Kirkpatrick DS, Vucic D: OTUB1 modulates c-IAP1 stability to regulate signalling pathways. EMBO J 32: 1103-1114, 2013
41. Juang YC, Landry MC, Sanches M, Vittal V, Leung CC, Ceccarelli DF, MateoAR, Pruneda JN,MaoDY, Szilard RK,Orlicky S,MunroM, Brzovic PS, Klevit RE, Sicheri F, Durocher D: OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2 enzyme function. Mol Cell 45: 384-397, 2012
42. Sato Y, Yamagata A, Goto-Ito S, Kubota K, Miyamoto R, Nakada S, Fukai S: Molecular basis of Lys-63-linked polyubiquitination inhibition by the interaction between human deubiquitinating enzyme OTUB1 and ubiquitin-conjugating enzyme UBC13. J Biol Chem 287: 25860 25868, 2012
43. Wiener R, Zhang X, Wang T, Wolberger C: The mechanism of OTUB1 mediated inhibition of ubiquitination. Nature 483: 618-622, 2012
44. Edelmann MJ, Iphöfer A, Akutsu M, Altun M, di Gleria K, Kramer HB, Fiebiger E, Dhe-Paganon S, Kessler BM: Structural basis and specificity of human otubain 1-mediated deubiquitination. Biochem J 418: 379 390, 2009
45. Ito K, Tsutsumi K, Kuzumaki T, Gomez PF, Otsu K, Ishikawa K: A novel growth-inducible gene that encodes a protein with a conserved coldshock domain. Nucleic Acids Res 22: 2036-2041, 1994
46. Mastrangelo MA, Kleene KC: Developmental expression of Y-box protein 1 mRNA and alternatively spliced Y-box protein 3 mRNAs in spermatogenic cells in mice. Mol Hum Reprod 6: 779-788, 2000
47. van Roeyen CR, Eitner F, Martinkus S, Thieltges SR, Ostendorf T, Bokemeyer D, Lüscher B, Lüscher-Firzlaff JM, Floege J, Mertens PR: Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease. J Am Soc Nephrol 16: 2985-2996, 2005
48. Jurchott K, Bergmann S, Stein U, Walther W, Janz M, Manni I, Piaggio G, Fietze E, Dietel M, Royer HD: YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression.JBiol Chem 278: 27988-27996, 2003
49. Ladomery M, Sommerville J: A role for Y-box proteins in cell proliferation. Bioessays 17: 9-11, 1995.
50. Shibao K, Takano H, Nakayama Y, Okazaki K, Nagata N, Izumi H, Uchiumi T, KuwanoM, Kohno K, ItohH: Enhanced coexpression of YB-1 and DNA topoisomerase II alpha genes in human colorectal carcinomas. Int J Cancer 83: 732-737, 1999.
51. Canaud G, Bonventre JV: Cell cycle arrest and the evolution of chronic kidney disease from acute kidney injury [published online ahead of print July 12, 2014]. Nephrol Dial Transplant
52. Hayakawa H, Uchiumi T, Fukuda T, Ashizuka M, Kohno K, Kuwano M, Sekiguchi M: Binding capacity of human YB-1 protein for RNA containing 8-oxoguanine. Biochemistry 41: 12739-12744, 2002
53. Lyden P, Levy H, Weymer S, Pryor K, Kramer W, Griffin JH, Davis TP, Zlokovic B: Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers. Curr Pharm Des 19: 7479 7485, 2013
54. Wang L, Jiang R, Sun XL: Recombinant thrombomodulin of different domains for pharmaceutical, biomedical, and cell transplantation applications. Med Res Rev 34: 479-502, 2014
55. Wei Q, Dong Z: Mouse model of ischemic acute kidney injury: Technical notes and tricks. Am J Physiol Renal Physiol 303: F1487-F1494, 2012
56. EsmonCT, Esmon NL, Le Bonniec BF, Johnson AE: ProteinCactivation. Methods Enzymol 222: 359-385, 1993
57. Taylor FB Jr, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE: Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 79: 918-925, 1987
58. WangH, Vinnikov I, Shahzad K, Bock F, Ranjan S,Wolter J, Kashif M,Oh J, Bierhaus A, Nawroth P, Kirschfink M, Conway EM, Madhusudhan T, Isermann B: The lectin-like domain of thrombomodulin ameliorates diabetic glomerulopathy via complement inhibition. Thromb Haemost 108: 1141-1153, 2012
59. Sheridan AM, Schwartz JH, Kroshian VM, Tercyak AM, Laraia J, Masino S, Lieberthal W: Renal mouse proximal tubular cells are more susceptible thanMDCK cells to chemical anoxia. Am J Physiol 265: F342-F350, 1993
60. Breggia AC, Himmelfarb J: Primary mouse renal tubular epithelial cells have variable injury tolerance to ischemic and chemical mediators of oxidative stress. Oxid Med Cell Longev 1: 33-38, 2008
61. Kashif M, Hellwig A, Hashemolhosseini S, Kumar V, Bock F, Wang H, Shahzad K, Ranjan S,Wolter J,Madhusudhan T, Bierhaus A, Nawroth P, Isermann B: Nuclear factor erythroid-derived 2 (Nfe2) regulates JunD DNA-binding activity via acetylation: A novel mechanism regulating trophoblast differentiation. J Biol Chem287: 5400-5411, 2012